Forsyth Medical Center 
Tests and Treatments
Endovascular Brachytherapy
| Approved in November 2000 by the FDA, endovascular brachytherapy provides patients with a new and effective option for reopening blockages. |
Coronary Artery Disease
Every year, more than 800,000 patients with coronary heart disease receive intracoronary stents - small, wire mesh tubes used to hold open an artery that has been cleared using angioplasty. Yet 1 in 5 of those patients experience restenosis - a condition in which stents become clogged with new tissue growth. Left untreated, it can cause a heart attack.
Endovascular Brachytherapy
Approved in November 2000 by the FDA, endovascular brachytherapy provides patients with a new and effective option for reopening blockages.
The procedure delivers localized radiation to the treatment area, preventing the growth of scar tissue cells.
Following FDA approval, specialists at Forsyth Cardiac & Vascular Center performed the region's first procedure. Today, you can discuss treatment options with any of the physicians on staff who are performing the procedure.
